Whats new

Whats new.

CLSA - Nearing the Checkpoint; Upcoming HNSCC trial readout & Ph3 NSCLC progress key focus in CY24; Mtn Buy, A$0.95 Tgt (Analyst: Andrew Paine)

March 5th 2024

For a copy of this research report please contact your CLSA advisor

Go back